Reportbuyer.com - Pharma & Healthcare: Diseaseshttp://www.reportbuyer.com/rss.htmlReportbuyer.com helps you stay ahead with advanced reports on Diseases. Information includes Competitive Positioning, Stakeholder Opinions and Future Market Watch.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comFSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART): Competitor Analysishttp://www.reportbuyer.com/pharma_healthcare/diseases/fsh_hcg_lh_therapeutic_proteins_assisted_reproductive_technology_art.htmlThe Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of November 2009 provides a competitor analysis in the development pipeline of novel recombinant, transgenic and oral FSH, hCG and LH receptor agonists for treatment of infertility. Follicle-stimulating hormone (FSH) now has become an established means of ovulation induction (OI) as part of assisted reproductive technology (ART). FSH is used to induce development of multiple follicles in ovulatory women and anovulatory infertile women. e60bfe459320797ace3778d4150aa4cdWed, 11 Nov 2009 12:00:00 GBPharma & Healthcare/DiseasesTGF-R Agonists and Antagonists: Competitor Analysishttp://www.reportbuyer.com/pharma_healthcare/diseases/tgf_r_agonists_antagonists.htmlThe present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TGF targeting molecules for tissue healing or treatment of cancer and fibrotic diseases of lung, skin or kidney as of November 2009. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. 8934ec4d9d9979a22bc949c4896b08a8Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcare/DiseasesCompetitor Analysis: EGF-R Agonists and Antagonistshttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/competitor_analysis_egf_r_agonists_antagonists.htmlThe present Competitive Intelligence Report about PDGF-R agonists and antagonists provides a competitor evaluation in the field of platelet derived growth factor receptor (PDGF-R) or PDGF targeting molecules for wound healing, bone formation or treatment of cancer as of October 2009. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report Growth factors are extracellular signaling polypeptides regulating cell proliferation, differentiation and survival. 10181620d4129b9cb0e7864a1967e4b7Sat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/DiseasesAlzheimer's Disease: New Drugs, Markets and Companieshttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimers/alzheimers_disease.htmlAlzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable research is in progress to understand the pathomechanism of the disease and find a cure. 3b4e9ea0d5fb2ffa62b6131d9a8740ceSat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/DiseasesWorldwide Market for Anti-Infectives: (Antifungals, Antibacterials and Antivirals), Thehttp://www.reportbuyer.com/pharma_healthcare/diseases/worldwide_market_anti_infectives.htmlThe anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to them. bca1cbdb61689001f051a90c9968a243Sat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/DiseasesInfectious Diseases Drugs Marketshttp://www.reportbuyer.com/pharma_healthcare/diseases/infectious_diseases_drugs_markets.htmlAccording to the World Health Organization (WHO), six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and young adults. What's more, threatening pandemics such as swine flu (H1N1 influenza A virus) are adding significant pressure to already strained healthcare budgets of governments around the world. This report provides a detailed description of the current infectious diseases drugs market and highlights the existing and developing anti-infective agents used to ameliorate diseases' afflictions on humankind. 4c97e3937820dbc13b84a214e934fa5fSat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/DiseasesChinese Markets for Bladder Cancer Treatment Drugshttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/chinese_markets_bladder_cancer_treatment_drugs.htmlChina's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. 1c3b970cc8706d389890272ecb3fd169Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesChinese Markets for Brain Cancer Treatment Drugshttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/chinese_markets_brain_cancer_treatment_drugs.htmlChina's demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. 31e6d3a9eea2cfa1afd1b528f0a70bc2Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesChinese Markets for Cervical Cancer Treatment Drugshttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/chinese_markets_cervical_cancer_treatment_drugs.htmlChina's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. 54ad51b55c8f32d9c83efa599e37faa8Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesThe Diabetes Market Outlook To 2014: Market Dynamics, Competitive Landscape, Emerging Therapieshttp://www.reportbuyer.com/pharma_healthcare/diseases/diabetes_market_outlook_2014.htmlDiabetes mellitus is a chronic metabolic disorder that results due to a failure of the body to produce the hormone insulin and/or an inability of the body to respond adequately to circulating insulin. Type 1 diabetes, previously referred to as insulin-dependent diabetes mellitus (IDDM), occurs most commonly in children or young adults and constitutes 5??. a228f93ecc42708dd1d785b22851e1c3Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesWorld Neurodegenerative Diseases Market 2009-2024http://www.reportbuyer.com/pharma_healthcare/diseases/world_neurodegenerative_diseases_market_2009_2024.htmlRising neurodegenerative disease prevalence and expanding patent populations - where are the best opportunities and how can you unlock these? Our new report - World Neurodegenerative Diseases Market 2009-2024 - explains. The ageing of the baby-boom generation, combined with new and emerging treatments for neurodegenerative disorders - including multiple sclerosis, Alzheimer's disease and Parkinson's disease - will lead to further expansion of the neurodegenerative therapies market. Increasing disease prevalence and a robust pipeline make that sector dynamic and highly promising for pharmaceutical and biotechnology companies worldwide. f8671b90bc8fcacf1301e084b8b71d9bWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesChinese Markets for Colon Cancer Treatment Drugshttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/chinese_markets_colon_cancer_treatment_drugs.htmlChina's demand for Colon Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. b2405ca9ab0fe82ca946adc4b4274206Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesCompetitor Analysis: Her2 Receptor Antagonistshttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/competitor_analysis_her2_receptor_antagonists.htmlThe present Competitive Intelligence Report about Her2 receptor antagonists provides a competitor evaluation in the field of Her2 (ErbB2) receptor targeting molecules for treatment of cancer as of September 2009. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. 2ea4f26dcf834fb8eb87acebfb767a0cWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesCancer Diagnostic Testing Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzershttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/cancer_diagnostic_testing_instrumentation.htmlThis report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing . edae6fe8b9615d8d249d08280a7d52e7Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesThe German Cancer Diagnostics Markethttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/german_cancer_diagnostics_market.htmlThis report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e. g. 3806351c66a7828b10c8802439700c59Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesThe Japanese Cancer Diagnostics Markethttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/japanese_cancer_diagnostics_market.htmlThis report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e. g. 61688f8b2a44a351f73a0a495baec423Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesCurrent and Emerging Cancer Diagnostic Tests: Emerging Assays and Companies Developing New Technologies and Productshttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/current_emerging_cancer_diagnostic_tests.htmlThe report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications. . aa6a15dcdc3add83c5dc205e9fdbc997Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesThe French Cancer Diagnostics Markethttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/french_cancer_diagnostics_market.htmlThis report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e. g. c25e141191c9c5aee4cc2fb1a5b27284Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesThe UK Cancer Diagnostics Markethttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/uk_cancer_diagnostics_market.htmlThis report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e. g. bf88c174981f1cc021f700bdb59ccf69Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/DiseasesCancer Diagnostic Testing: A Global Market Overview - Facilities, Test Volumes, and Sales Forecasts by Countryhttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/cancer_diagnostic_testing.htmlThis report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. The report looks at the following key areas: Worldwide Business Environment Worldwide Market Structure Worldwide Market Size and Growth . 1f35a8f2c8319a4e4b409cf9d1c613c9Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/Diseases